EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HTLV screening and confirmatory testing among blood donors in São Paulo: A cross‐sectional study

Suzete C Ferreira, Anna S Nishyia, Jerenice E Ferreira, Claudia Di Lorenzo Oliveira, Cesar de Almeida-Neto iD, Tila Fanciani, Katia C Dantas, Juliana Derriga iD, Silvia Petrossi Gallo Polato, Nanci Salles, Vanderson Rocha, Alfredo Mendrone-Junior

Transfusion Medicine · 27.07.2026

DOI: 10.1111/tme.70106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion Medicine, online erschienen am 27.07.2026. Verfasst von Suzete C Ferreira und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Research & Transfusion Medicine, Pro-Blood Foundation/Blood Center of São Paulo, São Paulo, Brazil. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujirebio Europe, CISCRE.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Human T‐cell lymphotropic virus types 1 and 2 (HTLV‐1/2) are transfusion‐transmissible retroviruses associated with severe diseases, and blood donor screening is mandatory in Brazil. Increasing HTLV‐related discard rates at our institution prompted this study to determine the prevalence and incidence of HTLV‐1/2 and to investigate the presence of HTLV‐3 among donations reactive in the ARCHITECT rHTLV‐I/II CMIA assay.

Methods

A retrospective cross‐sectional study was conducted among 220 340 volunteer blood donors at Fundação Pró‐Sangue/Hemocentro de São Paulo, Brazil, between September 2019 and July 2021. Real‐time PCR assays for HTLV‐1/2 and HTLV‐3 were performed. INNO‐LIA HTLV‐I/II was used as the confirmatory test for samples reactive in screening with the ARCHITECT rHTLV‐I/II CMIA assay.

Results

Among 220 340 donations, 404 (0.18%) were initially reactive by CMIA, and 223 (0.10%) were further analysed. Of these, 59 (26.5%) were confirmed HTLV‐1/2 positive by INNO‐LIA, and 42 (18.8%) were indeterminate. Annual rates of initially reactive donations were 0.20% (2019), 0.20% (2020), and 0.15% (2021). Overall HTLV prevalence was 0.027%, and incidence was 1.36 per 100 000 donations. Real‐time PCR detected HTLV DNA in 54 (24.2%) samples; no HTLV‐3 cases were identified. An S/CO cutoff ≥4.0 increased the positive predictive value from 47.6% to 66.1%.

Conclusion

These findings highlight the epidemiological and diagnostic challenges of HTLV‐1/2 in blood donors. Reliance solely on serological screening thresholds is limited, reinforcing the essential role of confirmatory molecular and serological testing to ensure accurate diagnosis and strengthen blood safety in Brazil.

Schlagwörter

Stichwörter der Autor:innen

HTLV‐1HTLV‐2blood donorschemiluminescent immunoassayhuman T‐cell lymphotropic virusseroprevalencetransfusion‐transmitted infections

Autor:innen und Institutionen

  • Division of Research & Transfusion Medicine, Pro-Blood Foundation/Blood Center of São Paulo, São Paulo, Brazil.
  • Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in OncoImmuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas, São Paulo, Brazil.
  • Respiratory Diseases Unit, Virology Center, Adolfo Lutz Institute, São Paulo, Brazil.
  • Faculty of Medicine, Federal University of São João del-Rei, São João del-Rei, Brazil.
  • Department of Medical Sciences, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
  • Department of Pathology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.

ORCID-Profile: Cesar de Almeida-Neto, Juliana Derriga

Förderung

  • Fujirebio Europe
  • CISCRE

Zitieren

APA

Ferreira, S. C., Nishyia, A. S., Ferreira, J. E., Oliveira, C. D. L., de Almeida-Neto, C., Fanciani, T., Dantas, K. C., Derriga, J., Polato, S. P. G., Salles, N., Rocha, V., & Mendrone-Junior, A. (2026). HTLV screening and confirmatory testing among blood donors in São Paulo: A cross‐sectional study. Transfusion Medicine. https://doi.org/10.1111/tme.70106

Vancouver

Ferreira SC, Nishyia AS, Ferreira JE, Oliveira CDL, de Almeida-Neto C, Fanciani T, et al. HTLV screening and confirmatory testing among blood donors in São Paulo: A cross‐sectional study. Transfusion Medicine. 2026. doi:10.1111/tme.70106

BibTeX
@article{Ferreira2026,
  author = {Ferreira, Suzete C and Nishyia, Anna S and Ferreira, Jerenice E and Oliveira, Claudia Di Lorenzo and de Almeida-Neto, Cesar and Fanciani, Tila and Dantas, Katia C and Derriga, Juliana and Polato, Silvia Petrossi Gallo and Salles, Nanci and Rocha, Vanderson and Mendrone-Junior, Alfredo},
  title = {HTLV screening and confirmatory testing among blood donors in São Paulo: A cross‐sectional study},
  journal = {Transfusion Medicine},
  year = {2026},
  doi = {10.1111/tme.70106}
}
Kostenlos starten →